Regulation of ovarian function: the role of anti-Müllerian hormone.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Reproduction

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/REP.0.1240601PMID 12416998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.

  2002cited by this paper
• Antimüllerian hormone serum levels: a putative marker for ovarian aging.

  2002cited by this paper
• Anti-Müllerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary.

  2002influential reference
• Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.

  2002cited by this paper
• Basic fibroblast growth factor induces primordial follicle development and initiates folliculogenesis.

  2001cited by this paper
• Müllerian Inhibitory Substance Induces Growth of Rat Preantral Ovarian Follicles1

  2001cited by this paper
• Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo

  2001cited by this paper
• Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.

  2001cited by this paper
• The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.

  2001influential reference
• Nerve growth factor is required for early follicular development in the mammalian ovary.

  2001cited by this paper
• Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.

  2001cited by this paper
• Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary.

  2001influential reference
• The type I BMP receptor BmprIB is essential for female reproductive function

  2001cited by this paper
• Controlling TGF-beta signaling.

  2000cited by this paper
• Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.

  2000cited by this paper
• Initial and cyclic recruitment of ovarian follicles.

  2000cited by this paper
• Müllerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism*

  2000cited by this paper
• Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay.

  2000cited by this paper
• In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats.

  2000influential reference
• Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors.

  2000cited by this paper
• Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.

  2000influential reference
• Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells.

  1999cited by this paper
• Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.

  1999cited by this paper
• Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis.

  1999cited by this paper
• Recombinant Growth Differentiation Factor-9 (GDF-9) Enhances Growth and Differentiation of Cultured Early Ovarian Follicles.

  1999influential reference
• Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary.

  1999cited by this paper
• Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors.

  1999cited by this paper
• Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility.

  1999cited by this paper
• Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency

  1999cited by this paper
• Paracrine actions of growth differentiation factor-9 in the mammalian ovary.

  1999cited by this paper
• Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles.

  1999cited by this paper
• Follicle-stimulating hormone enhances the development of preantral follicles in juvenile rats.

  1997cited by this paper
• Direct actions of kit-ligand on theca cell growth and differentiation during follicle development.

  1997cited by this paper
• Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility

  1997cited by this paper
• TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

  1997cited by this paper
• Clinical aspects and molecular genetics of the persistent Müllerian duct syndrome

  1997cited by this paper
• Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

  1996cited by this paper
• Growth differentiation factor-9 is required during early ovarian folliculogenesis

  1996cited by this paper
• A 27 base-pair deletion of the anti-müllerian type II receptor gene is the most common cause of the persistent müllerian duct syndrome.

  1996cited by this paper
• Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol.

  1996cited by this paper
• Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.

  1996cited by this paper
• Reversible and irreversible immobilization of enzymes on Graphite Fibrils.

  1996cited by this paper
• Immunoreactive inhibin, müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors.

  1996cited by this paper
• ANTIMULLERIAN HORMONE AS A SERUM MARKER OF GRANULOSA CELL TUMORS OF THE OVARY : COMPARATIVE STUDY WITH SERUM ALPHA -INHIBIN AND ESTRADIOL

  1996cited by this paper
• Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis.

  1995cited by this paper
• Müllerian inhibiting substance

  1995cited by this paper
• Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.

  1995influential reference
• Pathology of ovarian cancer precursors

  1995cited by this paper
• Müllerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection.

  1994influential reference
• Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.

  1994cited by this paper
• Müllerian-inhibiting substance function during mammalian sexual development.

  1994cited by this paper
• A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct.

  1994cited by this paper
• Model of antral follicle dynamics during the 5-day cycle in rats based on measurement of antral follicle inflow.

  1993cited by this paper
• Müllerian inhibiting substance production associated with loss of oocytes and testicular differentiation in the transplanted mouse XX gonadal primordium.

  1993cited by this paper
• The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells.

  1992cited by this paper
• Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.

  1992influential reference
• Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.

  1992cited by this paper
• Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.

  1992cited by this paper
• Human müllerian inhibiting substance inhibits tumor growth in vitro and in vivo.

  1991cited by this paper
• Expression of the mouse anti-müllerian hormone gene suggests a role in both male and female sexual differentiation.

  1991cited by this paper
• Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance

  1990cited by this paper
• The transforming growth factor-beta family.

  1990cited by this paper
• Ovarian follicle dynamics in immature rats treated with a luteinizing hormone-releasing hormone antagonist (Org. 30276).

  1989cited by this paper
• Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle.

  1989cited by this paper
• Effects of short-term injection of gonadotrophins on ovarian follicle development in hypogonadal (hpg) mice.

  1988cited by this paper
• Immunopurified anti-müllerian hormone does not inhibit spontaneous resumption of meiosis in vitro of rat oocytes.

  1988cited by this paper
• Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells.

  1986cited by this paper
• Müllerian inhibiting substance as oocyte meiosis inhibitor.

  1986cited by this paper
• Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.

  1985cited by this paper
• Effect of suppression of the surge of follicle-stimulating hormone with porcine follicular fluid on follicular development in the rat.

  1981cited by this paper
• Anti-Müllerian hormone

  1978cited by this paper
• Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy

  1978cited by this paper
• Obstetrics and Gynaecology

  1945influential reference
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary*

  year unknowninfluential reference

• Recent Advances in Anti-Mullerian Hormone (AMH)-Related Osteoporosis Research.

  2026cites this paper
• Comparative analysis of serum anti-Müllerian hormone (AMH) levels in sheep: the role of genetic background and physiological status

  2026cites this paper
• Cadmium exposure is associated with impaired ovarian function: Potential role of cadmium-induced ferroptosis in granulosa cells.

  2026cites this paper
• The role of anti-Müllerian hormone: insights into ovarian reserve, primary ovarian insufficiency, and menopause prediction

  2025influential citation
• Assisted Reproduction Therapy in Patients with Multiple Sclerosis: Narrative Review and Practical Recommendations

  2025cites this paper
• Establishment and Maintenance of Feline Pregnancy—A Comprehensive Review

  2025cites this paper
• Elevated estrogen receptor beta and oxidative stress in postmenopausal women with ovarian cancer

  2025cites this paper
• Unexpected Basal Anti-Müllerian Hormone Concentrations in a 6-Year-Old Bitch Presenting an Ovarian Remnant

  2025cites this paper
• Is serum AMH a suitable biomarker to determine litter size or fetal sex in goats?: A preliminary study

  2025cites this paper
• The Role of Anti-Müllerian Hormone in Ovarian Function and Folliculogenesis: A Literature Review

  2025cites this paper
• Cytokine Profiling and Puberty Enhancement Post Altrenogest Feeding in Prepubertal Murrah Buffalo (Bubalus bubalis) Heifers

  2025cites this paper
• Mechanisms of cell senescence and apoptosis in cyclophosphamide-induced premature ovarian failure in rats

  2025cites this paper
• Optimizing in vitro embryo production in cattle: strategies for donor management and selection

  2025cites this paper
• Anti-mullerian hormone in felids: A systematic review.

  2025cites this paper
• Beef cows with larger vulvar width have greater antral follicle count, viable oocytes, and higher circulating AMH

  2025cites this paper
• Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve

  2025cites this paper
• Effect of circulating anti-Mullerian hormone on the reproductive potential of gilts

  2025cites this paper
• Long-term effects of bipolar electrocoagulation and suture hemostasis on the ovarian reserve following endometriotic cystectomy: a meta-analysis

  2025cites this paper
• Assessing the potential of nifedipine and resveratrol to enhance ovarian viability in conjunction with detorsion treatment: A rat ovarian torsion model study

  2025cites this paper
• Advanced strategies in organoid/organ-on-a-chip for female reproductive diseases

  2025cites this paper
• Peritoneal Endometriosis Impairs Ovarian Reserve and Increases Atresia in a Rat Model

  2025cites this paper
• Anti-Müllerian hormone levels in relation to ovarian structures, season and age in Lipizzaner broodmares.

  2025cites this paper
• Single-cell-scale spatial transcriptome of the developing and adult mouse ovary

  2025cites this paper
• A biochemical study of estrogen receptor beta and oxidative stress in females with ovarian cancer.

  2025cites this paper
• Interrelationships between milk yield, anti-müllerian hormone levels, metabolic profile parameters, and first service conception rates in Simmental cows

  2025cites this paper
• Detection of c-Abl and mTERT expression by DMBA-ınduced mouse model of premature ovarian ınsufficiency

  2025cites this paper
• Integrated analysis of microRNA and mRNA interactions regulating fecundity in the ovaries of two distinct sheep breeds

  2025cites this paper
• Serum anti-Müllerian hormone (AMH) concentrations in pregnant and lactating dogs.

  2025cites this paper
• Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial

  2025cites this paper
• Characterization of Persistency of Lay in Laying Hens.

  2025cites this paper
• The Impacts of Periconceptional Alcohol on Neonatal Ovaries and Subsequent Adult Fertility in the Rat

  2024cites this paper
• Nicotine exposure is associated with targeted impairments in primordial follicle phenotype in cultured neonatal mouse ovaries.

  2024cites this paper
• Anti-Müllerian Hormone as a Predictor of Oocyte Yield Following Controlled Ovarian Stimulation in the Rhesus Macaque

  2024cites this paper
• Live birth rates in IVF patients with and without polycystic ovary syndrome according to serum anti-Müllerian hormone concentrations.

  2024cites this paper
• A Comparison of the Frequency of Trisomy 13, 18, and 21 Using Non-Invasive Prenatal Testing According to Diminished vs. Normal Egg Reserve and Age

  2024cites this paper
• Prospective Solutions to Ovarian Reserve Damage during the Ovarian Tissue Cryopreservation and Transplantation (OTC/T) Procedure.

  2024cites this paper
• Anti‐Müllerian hormone type II receptor protein expression in non‐small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferation

  2024cites this paper
• Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review

  2024cites this paper
• The Search for the Causes of Common Hyperandrogenism, 1965 to circa 2015.

  2024cites this paper
• Age-related Curves of AMH Using the Gen II, the picoAMH, and the Elecsys Assays in Women With Polycystic Ovary Syndrome

  2024cites this paper
• Comparative Analysis of Controlled Ovarian Hyperstimulation and Modified Natural Cycle Protocols on Gene Expression and Quality of Oocytes, Zygotes, and Embryos in Assisted Reproductive Technology (ART)

  2024cites this paper
• Age and serum anti-Müllerian hormone levels as predictors of time to return of menses after chemotherapy

  2024cites this paper
• The role of estrogen metabolites in human ovarian function.

  2024cites this paper
• The Role of Anti-Müllerian Hormone in Ovarian Function

  2024cites this paper
• Gene expression levels in cumulus cells are correlated with developmental competence of bovine oocytes.

  2024cites this paper
• Unilateral Oophorectomy and Age at Natural Menopause: A Longitudinal Community‐Based Cohort Study

  2024cites this paper
• Review: Environment of the ovulatory follicle: modifications and use of biotechnologies to enhance oocyte competence and increase fertility in cattle.

  2023cites this paper
• Global SUMOylation in mouse oocytes maintains oocyte identity and regulates chromatin remodeling and transcriptional silencing at the end of folliculogenesis.

  2023cites this paper
• The effects of human amnion membrane-derived mesenchymal stem cells conditioned medium on ionizing radiation-induced premature ovarian failure and endoplasmic reticulum stress-related apoptosis mechanism.

  2023cites this paper
• The roles of anti-Müllerian hormone in breast cancer

  2023cites this paper
• The Aging Ovary and the Tales Learned Since Fetal Development

  2023cites this paper
• Investigation of Serum Anti-Mullerian Hormone Levels at Follicular Phase and Interestrus Period in Queens

  2023cites this paper
• HGF-modified human umbilical cord mesenchymal stem cells rescue impaired ovarian reserve function in chemotherapy-induced POI rats by improving angiogenesis while decreasing apoptosis and fibrosis in the ovary.

  2023cites this paper
• Antimüllerian hormone (AMH) and age as predictors of preimplantation genetic testing for aneuploidies (PGT-A) cycle outcomes and blastocyst quality on day 5 in women undergoing in vitro fertilization (IVF)

  2023cites this paper
• Effects of Sleeve Gastrectomy on Patients with Obesity and Polycystic Ovary Syndrome: a Meta-analysis

  2023cites this paper
• Serum Anti-Müllerian Hormone Is an Effective Indicator of Antral Follicle Counts but Not Primordial Follicle Counts

  2023cites this paper
• Follicular Atresia, Cell Proliferation, and Anti-Mullerian Hormone in Two Neotropical Primates (Aotus nancymae and Sapajus macrocephalus)

  2023cites this paper
• Serum Anti-Mullerian Hormone (AMH) Levels Among Different PCOS Phenotypes and Its Correlation with Clinical, Endocrine, and Metabolic Markers of PCOS

  2023cites this paper
• Potential Role of Anti-Müllerian Hormone in Regulating Seasonal Reproduction in Animals: The Example of Males

  2023cites this paper
• Anti-Müllerian Hormone and Its Utility in Cattle Reproduction

  2023cites this paper
• Serum anti-Müllerian hormone (AMH) concentration during pregnancy: a longitudinal study

  2023cites this paper
• Rescue of follicle development after oocyte-induced ovary dysfunction and infertility in a model of POI

  2023cites this paper
• 2-Arachidonoylglycerol Activity in Over Ischemia Reperfusion Damage: Can Endocannabinoids Protect Ovarian Reserve?

  2023cites this paper
• Physiologie ovarienne

  2023cites this paper
• Decreased fertility in female mice lacking urokinase plasminogen activator.

  2023cites this paper
• The Associations of Vitamin D with Ovarian Reserve Markers and Depression: A Narrative Literature Review

  2023cites this paper
• Intergenerational effects on fertility in male and female mice after chronic exposure to environmental doses of NSAIDs and 17α-ethinylestradiol mixtures.

  2023cites this paper
• Anti-Müllerian Hormone promotes human osteoblast differentiation and calcification by modulating osteogenic gene expression

  2023cites this paper
• Serum antimüllerian hormone concentrations in female cats. Relation with ovarian remnant syndrome, ovarian cysts and gonadectomy status.

  2023cites this paper
• Gene-Based Therapy: A New Approach to Feline Induced Sterilization?

  2023cites this paper
• Diagnostischer Nutzen des Anti-Müller-Hormons in der Kleintierpraxis

  2023cites this paper
• Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome

  2023cites this paper
• Evaluation of Safety and Efficacy of Amniotic Mesenchymal Stem Cells for POI in Animals

  2023cites this paper
• The association of parity and breastfeeding with anti-Müllerian hormone levels at two time points.

  2022cites this paper
• Age-related changes in serum anti-Müllerian hormone in women of reproductive age in Kenya

  2022cites this paper
• Female reproductive system

  2022cites this paper
• Performance of Marmoset Monkeys as Embryo Donors Is Reflected by Different Stress-Related Parameters

  2022cites this paper
• Xenograft model of heterotopic transplantation of human ovarian cortical tissue and its clinical relevance

  2022cites this paper
• Anti-Müllerian hormone concentrations in female rabbits and its relation to spay status, pseudopregnancy and ovarian follicle numbers.

  2022cites this paper
• Two Synthetic Peptides Corresponding to the Human Follicle-Stimulating Hormone β-Subunit Promoted Reproductive Functions in Mice

  2022influential citation
• ANTIMULLARIAN HORMONE VARIATION THROUGHOUT THE MENSTRUAL CYCLE

  2022cites this paper
• Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis.

  2022cites this paper
• Anti-Müllerian hormone levels and breast cancer risk in the study of women’s health across the nation

  2022cites this paper
• Conteo de folículos antrales: Guía para la evaluación ultrasonográfica

  2022cites this paper
• Anti-Müllerian hormone treatment enhances oocyte quality, embryonic development and live birth rate

  2022cites this paper
• Targeting signaling pathways involved in primordial follicle growth or dormancy: potential application in prevention of follicular loss and infertility

  2022cites this paper
• Correlation of serum anti-Mullerian hormone with hormonal and environmental parameters in Brazilian climacteric women

  2022cites this paper
• Long-term role of neonatal microglia and monocytes in ovarian health.

  2022cites this paper
• The association between anthropometric factors and anti-Müllerian hormone levels in premenopausal women

  2022cites this paper
• Recent advances in understanding primary ovarian insufficiency [version 1; peer review: 3 approved]

  2022cites this paper
• To Compare the Research Progress of AMH and bFSH in the Reflection of Ovarian Function and the Predictive Value of Assisted Reproductive Outcomes

  2022cites this paper
• Protective effects of melatonin on female rat ovary treated with nonylphenol

  2022cites this paper
• Anti-Müllerian Hormone Inhibits FSH-Induced Cumulus Oocyte Complex In Vitro Maturation and Cumulus Expansion in Mice

  2022cites this paper
• Effects of IGF-1 on the Three-Dimensional Culture of Ovarian Preantral Follicles and Superovulation Rates in Mice

  2022cites this paper
• Expression of Anti-Müllerian Hormone and Its Type 2 Receptor in the Ovary of Pregnant and Cyclic Domestic Cats

  2022cites this paper
• The Evaluation of Ovarian Function Recovery Following Treatment of Primary Ovarian Insufficiency: A Systematic Review

  2022cites this paper
• Selective loss of kisspeptin signaling in oocytes causes progressive premature ovulatory failure

  2022cites this paper
• Cortisol safeguards oogenesis by promoting follicular cell survival

  2022cites this paper
• Normal Ovarian Ageing

  2022cites this paper
• Relationship between growth hormone levels and ovarian reserves

  2022cites this paper